{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:25:15Z","timestamp":1789907115390,"version":"4.0.1"},"reference-count":86,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T00:00:00Z","timestamp":1535846400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neuropsychopharm Rep"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>In this review, the author focused on anticraving therapy for alcohol use disorder (<jats:styled-content style=\"fixed-case\">AUD<\/jats:styled-content>) defined by<jats:styled-content style=\"fixed-case\">DMS<\/jats:styled-content>\u20105. A comprehensive review was carried out on the available published papers on anticraving drugs for treating<jats:styled-content style=\"fixed-case\">AUD<\/jats:styled-content>patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The author described all drugs with anticraving benefits for treating<jats:styled-content style=\"fixed-case\">AUD<\/jats:styled-content>patients approved by the Food and Drug Administration of the United States (<jats:styled-content style=\"fixed-case\">US FDA<\/jats:styled-content>) and European Medicines Agency of the European Union. Then, the commonly prescribed anticraving drugs and those under development were also described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The<jats:styled-content style=\"fixed-case\">US FDA<\/jats:styled-content>\u2010approved anticraving drugs included acamprosate and naltrexone, and those approved by European Medicines Agency were gamma\u2010hydroxybutyrate and nalmefene. The author also highlighted topiramate, gabapentin, ondansetron,<jats:styled-content style=\"fixed-case\">LY<\/jats:styled-content>196044, ifenprodil, varenicline,<jats:styled-content style=\"fixed-case\">ABT<\/jats:styled-content>\u2010436, mifepristone, citicoline, and baclofen. The putative mechanisms of action of and the use in clinical practice of those anticraving drugs were also described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although slowly developing, the field of anticraving drugs is getting into shape as a promising entity of a pharmaceutical class of drugs. Then, the author addressed on the underused issues of those recommended, and suggested anticraving drugs by the practice guideline of the American Psychiatric Association. The author urges that clinicians should be more \u201cadventurous\u201d in prescribing those promising drugs because benefits of those anticraving drugs are far\u2010outweighing the possible side effects of anticraving drugs, or the harms of untreated<jats:styled-content style=\"fixed-case\">AUD<\/jats:styled-content>itself.<\/jats:p><\/jats:sec>","DOI":"10.1002\/npr2.12028","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T06:56:47Z","timestamp":1535957807000},"page":"105-116","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Anticraving therapy for alcohol use disorder: A clinical review"],"prefix":"10.1002","volume":"38","author":[{"given":"Winston W.","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Psychiatry Wan Fang Medical Center Taipei Medical University Taipei Taiwan"},{"name":"Department of Psychiatry College of Medicine Taipei Medical University Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,2]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.40.9"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_13_4_1","volume-title":"[Clinical psychopharmacology for the 21st century, third edition]","author":"Shen WW","year":"2011"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.1750101"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/1355621031000117464"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.92"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2003"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01555.x"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00973.x"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12010"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110040006"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830030039007"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000079"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a008160"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agq083"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(99)00084-1"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1547237"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.4760"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.02.006"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114527362"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00922.x"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.9.905"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.14.1641"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.05.026"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(97)00084-3"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1108"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.11950"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.8.963"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.09.004"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12257"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17679"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00036-3"},{"key":"e_1_2_13_35_1","first-page":"95","article-title":"Influence of GIRK channel inhibition on alcohol abstinence and relapse risk in Japanese alcohol\u2010dependence outpatients","volume":"31","author":"Ogai Y","year":"2011","journal-title":"Jpn J Neuropsychopharmcol"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12001"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.11.017"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.214"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0757-1"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14070857"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14191"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.10.011"},{"key":"e_1_2_13_43_1","article-title":"Opioid and nondopamine reward circuitry and state\u2010dependent mechanisms","author":"Fujita M","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.07.033"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1578"},{"key":"e_1_2_13_46_1","first-page":"185","article-title":"Neurobiology of alcohol dependence","volume":"31","author":"Gilpin NW","year":"2008","journal-title":"Alcohol Res Health"},{"key":"e_1_2_13_47_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(24)39326-7","article-title":"\u03bc\u2010Opioid receptor knockout mice do not self\u2010administer alcohol","volume":"293","author":"Roberts AJ","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1423"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90257-X"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb05936.x"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3939"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.10.009"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5335.52"},{"key":"e_1_2_13_54_1","first-page":"403","article-title":"Distinctroles of opioid and dopamine systems in lateral hypothalamic intracranialself\u2010stimulation","volume":"20","author":"Ide S","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5274"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ps.40.020189.001203"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033808"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp006"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.14.4546"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2011.01.002"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0075-04.2004"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/34.2.244"},{"key":"e_1_2_13_63_1","first-page":"1597","article-title":"Serotonergic agents and alcoholism treatment: rebirth of serotonin subtype concept \u2014 a hypothesis","volume":"24","author":"Johnson BA","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.160.3835.1469"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853899009147915"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028208"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00008-9"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.1456"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/374135a0"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206779010468"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2003.03051.x"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/16019"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151242"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03944.x"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12163"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(83)90025-X"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2007.01718.x"},{"key":"e_1_2_13_78_1","first-page":"1","article-title":"Antidepressant therapy","volume":"15","author":"Shen WW","year":"2016","journal-title":"Aino J (Osaka)"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-2803-5_34"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320471"},{"key":"e_1_2_13_81_1","article-title":"Topiramate mitigates weight gain in antipsychotic\u2010treated patients with schizophrenia: meta\u2010analysis of randomised controlled trials","author":"Goh KK","year":"2018","journal-title":"Int J Psychiatry Clin Pract"},{"key":"e_1_2_13_82_1","first-page":"1776","article-title":"Medications for treating alcohol dependence","volume":"72","author":"Williams SH","year":"2005","journal-title":"Am Fam Physician"},{"key":"e_1_2_13_83_1","first-page":"263","article-title":"[Roles of GIRK channels in the reward system]","volume":"22","author":"Sugaya N","year":"2011","journal-title":"Jpn J Biol Psychiatry"},{"key":"e_1_2_13_84_1","first-page":"944","article-title":"How does alcohol molecule act on the brain","volume":"254","author":"Hironaka N","year":"2015","journal-title":"Med Ayumi"},{"key":"e_1_2_13_85_1","first-page":"13","article-title":"Role of GIRK channel in drug dependence","volume":"21","author":"Takamatsu Y","year":"2016","journal-title":"Brain"},{"key":"e_1_2_13_86_1","unstructured":"SchulzK.Did antidepressants depress Japan?New York Time Magazine August 22 2004."},{"key":"e_1_2_13_87_1","unstructured":"IngramsE.Long\u2010taboo \u2018mood disorder\u2019 is now being seen as the common and crippling disease it is. The Japan Times. July 10 2005."}],"container-title":["Neuropsychopharmacology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnpr2.12028","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.12028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T19:56:30Z","timestamp":1751831790000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/npr2.12028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1002\/npr2.12028"],"URL":"https:\/\/doi.org\/10.1002\/npr2.12028","archive":["Portico"],"relation":{},"ISSN":["2574-173X","2574-173X"],"issn-type":[{"value":"2574-173X","type":"print"},{"value":"2574-173X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"2018-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}